On February 04, Mustang Bio, Inc. (MBIO) filed a Statement of Ownership with the Securities Exchange Commission. While the stock was already in the green
Mustang Bio, Inc. (MBIO) is a leading biotherapeutics firm engaged in development of gene therapies to cure oncological disorders. One of the lead pipeline candidate
China Automotive Systems Inc. (CAAS) stock soared 2.38% to $10.75 in the pre-market trading after reporting that it shipped approximately 120,000 units from its portfolio
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.